Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I, Davison M
Proteomics Group, Enabling Science and Technology (Biology), CTL, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 7TG, UK.
Proteomics. 2001 Mar;1(3):377-96. doi: 10.1002/1615-9861(200103)1:3<377::AID-PROT377>3.0.CO;2-6.
Fluorescence two-dimensional differential gel electrophoresis (2-D DIGE*) is a new development in protein detection for two-dimensional gels. Using mouse liver homogenates (control and paracetamol (N-acetyl-p-aminophenol, APAP)-treated), we have determined the quantitative variation in the 2-D DIGE process and established statistically valid thresholds for assigning quantitative changes between samples. Thresholds were dependent on normalised spot volume, ranged from approximately 1.2 fold for large volume spots to 3.5 fold for small volume spots and were not markedly affected by the particular cyanine dye combination or by multiple operators carrying out the dye labelling reaction. To minimise the thresholds, substantial user editing was required when using ImageMaster 2D-Elite software. The difference thresholds were applied to the test system and quantitative protein differences were determined using replicate gels of pool samples and single gels from multiple individual animals (control vs treated in each gel). Throughout, the differences revealed with a particular cyanine dye combination were mirrored almost without exception when the dye combination was reversed. Both pool and individual sample analyses provided unique data to the study. The inter-animal response variability in inbred mice was approximately nine times that contributed by the 2-D DIGE process. A number of the most frequently observed protein changes resulting from APAP-treatment were identified by mass spectrometry. Several of these can be rationalised based on available data on the mechanism of APAP hepatotoxicity but others cannot, indicating that proteomics can provide further insights into the biochemical basis of APAP toxicity.
荧光二维差异凝胶电泳(2-D DIGE*)是二维凝胶蛋白质检测方面的一项新进展。我们使用小鼠肝脏匀浆(对照和对乙酰氨基酚(N-乙酰对氨基酚,APAP)处理组),确定了二维差异凝胶电泳过程中的定量变化,并建立了具有统计学意义的有效阈值,用于确定样品之间的定量变化。阈值取决于标准化斑点体积,对于大体积斑点约为1.2倍,对于小体积斑点为3.5倍,并且不受特定菁染料组合或进行染料标记反应的多个操作人员的显著影响。为了最小化阈值,使用ImageMaster 2D-Elite软件时需要大量用户编辑。将差异阈值应用于测试系统,并使用混合样品的重复凝胶和来自多只个体动物的单凝胶(每块凝胶中的对照与处理组)确定蛋白质定量差异。在整个过程中,当染料组合颠倒时,特定菁染料组合所揭示的差异几乎毫无例外得到反映。混合样品和个体样品分析均为该研究提供了独特的数据。近交系小鼠个体间的反应变异性约为二维差异凝胶电泳过程变异性的九倍。通过质谱鉴定了一些由APAP处理导致的最常见的蛋白质变化。其中一些可以根据关于APAP肝毒性机制的现有数据进行合理解释,但其他一些则不能,这表明蛋白质组学可以为APAP毒性的生化基础提供进一步的见解。